Arcutis Biotherapeutics
ARQT
ARQT
133 hedge funds and large institutions have $347M invested in Arcutis Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 40
1% less funds holding
Funds holding: 134 → 133 (-1)
3% less capital invested
Capital invested by funds: $357M → $347M (-$9.94M)
Holders
133
Holding in Top 10
1
Calls
$562K
Puts
$557K
Top Buyers
| 1 | +$38.6M | |
| 2 | +$23.7M | |
| 3 | +$15M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.9M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$10.3M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$10.2M | |
| 3 | -$9.16M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$7.16M |
| 5 |
Holocene Advisors
New York
|
-$6.4M |